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Abstract
Aims/hypothesis The aimof this studywas to compare cognitive
function in adults with type 1 diabetes who have impaired aware-
ness of hypoglycaemiawith thosewho have normal awareness of
hypoglycaemia. A putative association was sought between cog-
nitive test scores and a history of severe hypoglycaemia.
Methods A total of 68 adults with type 1 diabetes were
included: 33 had impaired and 35 had normal awareness of
hypoglycaemia, as confirmed by formal testing. The groups
were matched for age, sex and diabetes duration. Cognitive
tests of verbal memory, object-location memory, pattern
separation, executive function, working memory and process-
ing speed were administered.
Results Part ic ipants with impaired awareness of
hypoglycaemia scored significantly lower on the verbal and
object-locationmemory tests and on the pattern separation test
(Cohen’s d −0.86 to −0.55 [95% CI −1.39, −0.05]).
Participants with impaired awareness of hypoglycaemia had
reduced planning ability task scores, although the difference
was not statistically significant (Cohen’s d 0.57 [95% CI 0,
1.14]). Frequency of exposure to severe hypoglycaemia
correlated with the number of cognitive tests that had not been
performed according to instructions.
Conclusions/interpretation Impaired awareness of
hypoglycaemia was associated with diminished learning,
memory and pattern separation. These cognitive tasks all
depend on the hippocampus, which is vulnerable to
neuroglycopenia. The findings suggest that hypoglycaemia
contributes to the observed correlation between impaired
awareness of hypoglycaemia and impaired cognition.
Keywords Cognitive function . Hypoglycaemia . Impaired
awareness of hypoglycaemia .Memory . Pattern separation .
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A diminished ability to perceive the onset of hypoglycaemia
occurs in 17–25% of people with type 1 diabetes [1, 2].
Impaired awareness of hypoglycaemia (IAH) is a major risk
factor for severe hypoglycaemia (SH), defined as an event
requiring external assistance, and increases the risk of SH
sixfold [1, 3]. Cognitive decline may be a complication of
longstanding type 1 diabetes [4], and several cognitive
domains seem to be affected [4–7]. Cognitive dysfunction
may therefore contribute to suboptimal diabetes management,
including the avoidance and treatment of hypoglycaemia. In
support of this hypothesis, some adults with IAH do not mod-
ify their behaviour to prevent or avoid hypoglycaemia [3], and
fail to adhere to recommended therapeutic measures [8].
Recurrent exposure to hypoglycaemia is strongly implicat-
ed in the pathogenesis of IAH [9]. A putative association
between IAH and impaired cognitive function may therefore
exist, since both could be the consequence of recurrent SH, the
frequency of which is promoted by IAH [1, 3]. Alternatively,
for people with type 1 diabetes who have premorbid cognitive
dysfunction, self-management may be suboptimal, thereby
increasing the risk of IAH. Furthermore, the development of
IAH and impaired cognitive function may have a common
predisposing factor. If IAH is associated with premorbid cog-
nitive dysfunction, impairment should involve several cogni-
tive domains. Alternatively, if cognitive impairment in people
with IAH is caused by recurrent SH, then we would expect
cerebral functions dependent on brain regions that are vulner-
able to hypoglycaemia to be diminished.
A causal association between recurrent SH and cognitive
impairment in adults with type 1 diabetes is unproven.
Anecdotal reports have described memory loss following SH
[10–12], and cross-sectional studies have demonstrated im-
pairment of several cognitive domains in adults with a history
of SH [13–16]. However, the Epidemiology of Diabetes
Interventions and Complications (EDIC) study (the follow-
up to the DCCT) and a smaller Swedish prospective study
both found that recurrent SH had little or no adverse effect
on cognition in adults with type 1 diabetes [17, 18], a conclu-
sion supported by a meta-analysis [5]. A more recent meta-
analysis concluded that reduced memory and executive func-
tion are associated with SH [7], which people with IAH expe-
rience at a much higher frequency than was recorded in the
DCCT/EDIC study. SH may cause localised neuronal death
within the hippocampus and cerebral cortex, and in white
matter, as demonstrated histologically and in vivo with MRI
after SH in animals and humans [11, 19–21]. It is therefore
plausible that recurrent SH could compromise cognitive func-
tions that are dependent on brain regions particularly sensitive
to neuroglycopenia.
Three previous studies in the early 1990s found a possible
association between IAH and cognitive impairments,
including memory impairment, selective attention and a trend
towards reduced intelligence quotient. These investigators
hypothesised that the impairments resulted from frequent
exposure to SH, as experienced by people with IAH
[22–24]. However, putative associations between IAH, recur-
rent hypoglycaemia and cognitive dysfunction have remained
unresolved.
The aim of the present study was to compare cognitive
function in people with type 1 diabetes who had established
IAH, with those in whom hypoglycaemia awareness remained
intact. For this purpose, tests of verbal memory, object-
location memory, pattern separation, working memory, infor-
mation processing speed and executive function, including
planning, were applied. Optimal cognitive function depends
on interaction within networks of brain regions. For learning,
memory, and pattern separation abilities, the most central
structure for normal functioning is the hippocampus [25,
26], while executive functions, working memory and infor-
mation processing speed depend on frontal and parietal corti-
ces and their connectivity [27, 28]. The intention was to test
cognitive abilities that depend on brain regions susceptible to
damage during hypoglycaemia [11, 21] and cognitive abilities
that are recognised to be impaired in patients with type 1
diabetes [4, 5]. Finally, because many people with IAH do
not modify their behaviour to avoid SH [3], exemplified by
some failing to measure their blood glucose in relation to
driving [29, 30], executive functions that include planning
ability [31] and pattern separation, which can affect a person’s
ability to identify a hypoglycaemic episode, were assessed. A
secondary aim was to assess whether cognitive function in
participants with IAH is related to their historical SH burden.
Methods
Participants
Adults with type 1 diabetes with IAH (Gold score ≥4) and
with normal hypoglycaemia awareness (Gold score 1–2) [3]
were recruited from a cross-sectional survey of the outpatient
population with type 1 diabetes attending St Olavs Hospital,
Trondheim, Norway [2]. In that survey, questionnaires were
posted to 636 adults with type 1 diabetes and returned by 70%,
with 440 questionnaires suitable for analysis. From these, 74
people with IAH were identified (17%). Autonomic dysfunc-
tion and peripheral neuropathy has previously been investigat-
ed in this patient sample [32]. The present study excluded
people with IAH aged >65 years (n=7), people who used
medication that could influence test results (n=5) and those
with severe comorbidity such as previous head injury, psychi-
atric, neurological or other systemic disease, or reduced vision
or hearing (n=6).
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In total, 56 people with IAH were eligible; of these, 33
agreed to participate. From those people with normal
hypoglycaemia awareness (NAH) in the survey, individuals
of the same sex and of similar age and diabetes duration
(±5 years) were selected at random. In total, 59 people with
NAH were identified as possible participants. Of these, 16
were not eligible (age >65 years, n=4; neurological comor-
bidity, n = 8; other severe comorbidity, n = 4), and eight
declined to participate. The NAH group therefore comprised
35 participants
Diabetes duration was confirmed from hospital records. On
the day of testing, participants documented their insulin regi-
men, frequency of self-monitoring of blood glucose (SMBG),
and current medication in a questionnaire. They also reported
the occurrence of SH experienced in the preceding year (no
episode, 1–2 episodes or ≥3 episodes) and from diagnosis (no
episode, 1–2 episodes, 3–5 episodes or ≥6 episodes).
Educational history was categorised into: level 1, grades
1–10, primary/lower secondary school; level 2, upper second-
ary school; level 3, ≤4 years at university/college; and level 4,
>4 years of tertiary education. Blood and urine samples were
obtained for the measurement of HbA1c and albumin/
creatinine ratio, respectively, and BP was measured. To cor-
roborate the classification of hypoglycaemia awareness, par-
ticipants’Gold scores were re-measured [3] and Clarke scores
were completed [33]. Data from routine ophthalmological
assessment were obtained from case records.
The study was approved by the regional medical ethics
committee (2012/439). All participants gave written informed
consent.
Preparations and precautions
As antecedent hypoglycaemia may influence cognitive test
performance [34], participants were requested to apply less
strict glycaemic targets for 24 h before cognitive testing.
Furthermore, they were requested to abstain from drinking
alcohol, to perform frequent SMBG to avoid plasma glucose
values of <4.0 mmol/l and not to exercise for 24 h before
testing. Tests were postponed if SH had occurred within the
previous week.
Cognitive tests
Six cognitive tests were applied via the self-administered web-
based neuropsychological test platform, Memoro (Trondheim
fMRI group, NTNU, Norway) [35, 36]. The cognitive tests
assessed verbal and object-location memory, working
memory, planning abilities, and coding. In addition, the ability
to learn and recall distinct non-overlapping representations of
highly similar everyday objects, namely pattern separation
[25], was assessed. See electronic supplementary material
(ESM) Methods for test details. Fifty-nine participants
performed the tests in a quiet room at St Olav’s Hospital.
The remaining nine participants (eight participants with IAH
and one participant with NAH) performed the tests at home
because of long travelling distances or unavoidable work
commitments. Memoro test scores have been shown not to
differ when tests are performed at home compared with a
controlled laboratory setting [33]; this finding was confirmed
in the current dataset (lowest p value: Mann–Whitney U tests,
exact significance p=0.106). Participants with type 1 diabetes
performed SMBG before and after testing, and plasma glucose
had to be ≥4.5 mmol/l before testing could commence.
Participants followed standardised aural and written instruc-
tions including pre-trial tests provided by the test platform. A
research assistant was available for technical support in a
nearby room (for in-hospital testing) or by telephone (for
home testing). Participants also completed the Memoro short
computer questionnaire, which gives a computer familiarity
score [35, 36].
For illustrative purposes only, scores on each test for the
two groups are displayed relative to scores from the Memoro
control population (i.e. non-diabetic) database (n= 197).
Statistical comparisons were, however, limited to IAH–NAH
between-group differences, in line with the study aims.
Blinding
TIH and AKH were blinded as to whether participants had
diabetes and to their hypoglycaemia awareness status during
data collection and analysis.
Statistical analyses
Demographic and type 1 diabetes related data Differences
between the IAH and NAH groups were investigated using
independent t tests for normally distributed data and Mann–
Whitney U tests for non-normally distributed data. χ2 or
Fisher’s exact tests were performed on cross-tabular data, as
appropriate.
Cognitive test scoresAll raw scores were transferred from the
Memoro database to an IBMSPSS Statistics software (version
22.0, Chicago, IL, USA) data file. The Tower test illegal
moves variable was log10 transformed to approximate a nor-
mal distribution. Test scores clearly demonstrating that a par-
ticipant hadmisinterpreted the instructions were excluded on a
case-by-case basis (for example, if a participant indicated at
the start of the Pattern separation test that novel stimuli had
been presented previously). For Fig. 1, the IAH and NAH raw
scores were standardised against the Memoro test norms.
Standardised scores for the Tower test were inverted such that
a low value represents poorer performance.
Independent t tests were used to investigate statistical differ-
ences between the IAH and NAH groups, and Cohen’s d with
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95% CI was calculated to estimate the effect size. Repeated
measures ANOVAwas used to investigate whether a difference
in performance was present throughout all trials in the verbal
memory test, and whether an interaction existed between
groups and trials. Spearman’s rank correlation analyses were
performed to investigate the association between test scores
and the number of SH episodes for all participants with dia-
betes, and separately for the IAH and NAH groups. Linear
regression models were used to investigate the relationship
between test performance and plasma glucose level.
Statistical significance and data presentation For all statis-
tical tests, the threshold for statistical significance was set at
p≤0.05, two tailed. Results from normally distributed data are
given as mean±SD, and from non-normally distributed data
as median and interquartile range (IQR) or frequency and
percentage.
Supplementary analyses
In the present study, awareness status had changed in five
participants between the cross-sectional study of 2011 and this
study. Supplementary analyses were therefore performed after




The study included 68 participants with type 1 diabetes com-
prising two groups: 33 with IAH (19 men) and 35 with NAH
(21 men). As shown in Table 1, the two groups were of similar
age, diabetes duration, and had similar BP, HbA1c level, insu-
lin regimen, prevalence of microvascular complications, edu-
cational level and computer familiarity.
No differences were observed in age, diabetes duration, sex
distribution, HbA1c level or frequency of SH during the pre-
ceding year between the 68 participants and the 31 candidates
(23 with IAH and eight with NAH) who declined participation
(see ESM Table 2).
Participants with IAH recorded more episodes of asymp-
tomatic hypoglycaemia (plasma glucose <3.9 mmol/l) during
the month preceding the study (Fisher’s exact test =20.558,
p<0.001; Table 1) compared with participants with NAH. In
addition, participants with IAH reported a higher number of
SH episodes during the preceding year, although this was not
statistically significant (χ21,68= 3.077, p=0.079). None of the
participants had experienced SH within 60 days of the start of
the study.
No participant developed hypoglycaemia during cognitive
testing, which took approximately 52 min. In two participants
with NAH, plasma glucose readings were 4.3 mmol/l and
4.2 mmol/l, respectively, after performing the tests. Data from
these participants were not excluded since cognitive dysfunc-
tion does not commence until the plasma glucose level
approaches 3.2 mmol/l in people with type 1 diabetes [37];
this value is even lower in people with IAH [34]. The mean
plasma glucose levels before and after the cognitive tests were
similar in both groups (Table 1).
Cognitive test results
The raw scores from different cognitive tests and statistical
comparisons between groups are presented in Table 2. Some
participants failed to perform the tests as instructed (these
were denoted invalid tests); therefore, only data for partici-
pants with valid scores are shown.
The scores in participants with IAHwere significantly low-
er compared with those of participants with NAH on the
Verbal memory distraction recall and delayed recall, Objects
in grid and Pattern separation tests (Table 2). The verbal mem-
ory learning curves demonstrate that participants with IAH
generally had poorer recall than participants with NAH
(Fig. 2). A significant group effect was observed across the
trials (F1,60= 7.123, p=0.010), but no interaction was found
between group and trials. No differences were found between
participants with IAH and NAH on the Digit span backwards,
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Fig. 1 Scores for the nine cognitive measures were standardised against
Memoro test norms for a non-diabetic population. BPS, behavioural pat-
tern separation. Black bars, IAH; grey bars, NAH
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moves scores. Reduced performance in participants with IAH
was observed in the Tower test illegal moves and Coding tests,
although the difference was not significant (Table 2).
Plasma glucose levels after testing had a significant
(r=0.405, p=0.02) correlation with Digit span backwards
scores in the NAH group, i.e. results in this test were better in
participants with higher glucose levels, but plasma glucose be-
fore or after testing did not correlate with performance on any
other test in either group. Adding plasma glucose level as a
covariate when comparing Digit span backwards scores for the
IAH and NAH groups did not alter the results. Six participants
(two with IAH, four with NAH) had plasma glucose levels of
Table 1 Characteristics of the
IAH and NAH groups Characteristic IAH (n= 33) NAH (n= 35)
Age, years 47 ± 10 47 ± 10
Sex (men: women), % 58:42 60:40
Age of diabetes onset, median (IQR) 16 (11–26) 13 (10–24)
Diabetes duration, years 30.1 ± 9.6 30.2 ± 10.4
Education, median (IQR) 2 (1–4) 2 (1–4)
Computer familiarity scorea 28.0 ± 4.2 28.7 ± 5.0
Plasma glucose level, mmol/l
Pre-testing 10.4 ± 2.9 10.3 ± 3.9
Post-testing 10.0 ± 3.2 10.0 ± 4.0
BP, mmHg
Systolic 120.8 ± 15.9 120.0 ± 13.7
Diastolic 73.2 ± 7.8 73.5 ± 7.5
HbA1c level, % 7.9 ± 1.6 8.0 ± 1.1
HbA1c level, mmol/mol 63.0 ± 17.8 64.0 ± 12.1
Participants performing SMBG ≥4 times per day, n (%) 17 (51.5) 17 (48.6)
Insulin regimen, n (%)
Long + rapid acting analogue 18 (54.5) 16 (45.7)
NPH insulin + rapid acting analogue 7 (21.2) 7 (20.0)
CSII with rapid acting analogue 8 (24.2) 11 (31.4)
Biphasic insulin 0 1 (2.9)
Retinopathy, n (%)
None 14 (42.4) 16 (45.7)
Non-proliferative 14 (42.4) 14 (40.0)
Mild/moderate proliferative 5 (15.1) 5 (14.3)
Visual acuityb in best eye, n (%)
≥1.0 28 (84.8) 29 (82.9)
<1.0 but ≥0.70 4 (12.1) 6 (17.1)
<0.70 but ≥0.50 1 (3.0) 0 (0)
Urinary albumin-to-creatinine ratioc
Median (IQR), mg/mmol 0.9 (0.55–2.0) 0.8 (0.5–2.2)
<3 mg/mmol, n (%) 25 (86.2) 27 (79.4)
≥3 mg/mmol, n (%) 4 (13.8) 7 (20.6)
SH episodes, n (%)
Since diagnosis
None 6 (18.2) 7 (20.0)
1–2 1 (3.0) 6 (17.1)
3–5 6 (18.2) 5 (14.3)
≥6 20 (60.6) 17 (48.6)
In preceding year
None 20 (60.6) 28 (80.0)
1–2 9 (27.3) 6 (17.1)
≥3 4 (12.1) 1 (2.9)
Asymptomatic hypoglycaemiad during preceding month, n (%)e
Never 9 (27.3) 24 (68.6)
1–3 times 5 (15.2) 8 (22.9)
Once/week 2 (6.1) 1 (2.9)
≥ Twice/week 17 (51.5) 2 (5.7)
Data are mean ± SD, unless otherwise stated
a Self-assessment of computer familiarity, range 0–35
bA score of 1 = 6/6
c Data from 29 participants with IAH and 34 participants with NAH
d Plasma glucose level of <3.9 mmol/l without symptoms
e Fisher’s exact test = 20.558, p< 0.001
CSII, continuous subcutaneous insulin infusion
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>15 mmol/l before the tests. Re-analysis excluding these partici-
pants did not affect between-group differences for any test.
Figure 2 shows a comparison of the performance of the
IAH and NAH groups standardised against Memoro test
norms for a non-diabetic population. In general, the perfor-
mance of the IAH group was poorer compared with the NAH
group across all tests. Furthermore, scores in the IAH group
deviated most from the norms.
No significant correlations were demonstrated between scores
for the different cognitive tests and the approximate number of
SH episodes (since diagnosis or during the preceding year).
However, in the IAH group, a significant correlation was found
between the number of invalid tests and the number of SH epi-
sodes since diagnosis (Spearman’s ρ=0.57, p=0.026).
When the five participants whose hypoglycaemia aware-
ness status had changed were excluded from the statistical
analysis, the between-group differences for cognitive tests
became more prominent (see ESM Results and ESM Fig. 1).
Furthermore, a significant between-group difference for
Tower test illegal moves scores emerged (p=0.047, Cohen’s
d 0.61 [95% CI 0.02, 1.19]), i.e. the performance of partici-
pants with IAH was significantly worse compared with par-
ticipants with NAH; this finding had been a non-significant
trend in the analysis using the original IAH cohort.
Discussion
By employing an extensive cognitive test battery and validat-
ed methods to assess hypoglycaemia awareness in well-
matched participants with type 1 diabetes, the present study
demonstrated that adults with type 1 diabetes who have IAH
have modestly impaired cognitive performance compared
with people with NAH, thus adding further evidence to pre-
vious reports on this topic [22–24].
The IAH group exhibited significant impairment in pattern
separation abilities in comparison with the NAH group, as
well as on supplementary analyses of planning function (the
Tower test illegal moves). Pattern separation is critical for
accurate memory: decreased pattern separation ability contrib-
utes to interference among memories and convergence of sim-
ilar episodes into a generalised representation rather than dis-
tinct memories [25]. It is possible that people with IAH have a
diminished ability to distinguish cues that are specifically
associated with hypoglycaemia and hence are unable to take
Table 2 Results of cognitive
tests and comparisons of the IAH
and NAH groups
Cognitive test IAH group NAH group p Cohen’s d (95% CI)
na Mean ± SD na Mean ± SD
Verbal memory testb
Distraction recall 32 6.4 ± 2.3 35 8.3 ± 3.1 0.007 −0.70 (−1.18, −0.2)
Post-distraction recall 32 12.3 ± 2.6 35 13.2 ± 2.6 0.179 −0.34 (−0.83, 0.14)
Delayed recall 32 12.4 ± 2.2 32 13.7 ± 2.1 0.018 −0.62 (−1.11, −0.10)
Objects in gridb 30 7.9 ± 3.1 34 9.9 ± 4.7 0.043 −0.55 (−1.05, −0.05)
Pattern separationb 28 0.19± 0.20 33 0.35 ± 0.17 0.001 −0.86 (−1.39, −0.34)
Digit span backwardsb 29 9.2 ± 2.7 33 9.9 ± 2.8 0.328 −0.25 (−0.76, 0.25)
Codingb 27 29.2 ± 8.1 34 34.4 ± 11.6 0.051 −0.52 (−1.02, 0.01)
Tower testc
Total moves 24 57.5 ± 9.4 25 54.0 ± 6.6 0.142 0.43 (−0.13, 1.0)
Log illegal moves 24 0.46± 0.29 25 0.29 ± 0.31 0.057 0.57 (0, 1.14)
a Number of valid responses
b Higher scores indicate better performance





















































Fig. 2 Mean (±SD) performance throughout the Verbal memory test.
The between-group difference is significant (repeated measures
ANOVA p = 0.01 with a non-significant interaction). Black solid line,
IAH; grey dashed line, NAH
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appropriate action to avoid SH. Executive function measured
with the Tower test in the present study assesses planning
ability and, as such, a person’s capacity to adjust behaviour
to current and future demands and goals [31]. The present
results suggest that planning ability may be restricted in peo-
ple with IAH and might underlie the observation that many
people with IAH do not modify their behaviour to prevent
hypoglycaemia [3] or adhere to prescribed therapy [8].
In the IAH group, significant impairments were observed in
the learning, memory and pattern separation tests, all of which
rely on the integrity of the hippocampus, a brain structure vul-
nerable to neuroglycopenic injury [11, 19, 20]. In people with
type 1 diabetes, learning and memory seem to be largely unaf-
fected [5, 17], although two studies have shownmemory impair-
ment in people with recurrent SH [24, 38]. In the present study,
participants with IAH exhibited both learning difficulties and
impaired delayed recall in the Verbal memory test. An IAH-
specific learning deficit was also evident in the Objects in grid
test, which is an object-location memory and one-trial learning
test. Hence, the impairment in memory and learning in those
with IAH was generalised, pertaining both to words heard and
objects seen. The difference between the IAH and NAH groups
in the Verbal memory test is similar to the difference observed
after 7 years of ageing in a middle-aged non-diabetic population
[39]. The deficits observed in the present study are subtle and
unlikely to be apparent to individuals in the performance of
everyday tasks. However, the present findings suggest that adults
with type 1 diabetes who have developed IAH may have a re-
duced cognitive reserve compared with those with NAH, which
may render them more susceptible to experiencing subsequent
cognitive decline and associated educational and occupational
challenges.
These findings suggest that frequent exposure to SH, as
experienced by people with IAH, may underlie the observed
cognitive impairments. However, causation cannot be deter-
mined from cross-sectional data. The lack of correlation
between the frequency of SH episodes and cognitive test
results may indicate that the observed association between
IAH and cognitive deficits did not result from exposure to
SH; instead, it might be explained by inaccurate recall of SH
episodes, since it is known that retrospective estimation of
hypoglycaemia is vulnerable to recall bias [40]. An associa-
tion was found between the number of invalid tests and the
number of SH episodes since diabetes onset in participants
with IAH, which supports the hypothesis that recurrent SH
may promote cognitive impairment.
The participants’ premorbid cognitive function was not
assessed, and it is therefore not possible to establish whether
(1) the cognitive impairment associated with IAH had resulted
from recurrent exposure to SH, (2) premorbid cognitive im-
pairment per se predisposed the individual to develop IAH, or
(3) another common predisposing factor led to the simulta-
neous development of IAH and cognitive impairment. Since
the IAH group did not exhibit impairment across all cognitive
domains, but had significant impairments in tests of learning
and memory that are associated with brain regions vulnerable
to neuroglycopenia [11, 19, 20], the present results support a
role for recurrent SH in the pathogenesis of IAH [9].
The awareness status of a few of the participants had changed
between the cross-sectional study of 2011 and the present study.
This is consistent with the dynamic nature of the IAH syndrome:
awareness status may fluctuate and may even be restored by
avoidance of hypoglycaemia [41]. When excluding the five par-
ticipants whose hypoglycaemia awareness status had changed,
group differences becamemore evident, thus demonstrating that
persistent IAH status was most negatively associated with cog-
nitive deficiency. Participants with IAH tended to have experi-
enced more SH overall compared with participants with NAH
and recorded more asymptomatic hypoglycaemia during the
month preceding the study, consistent with the recognised char-
acteristics of the IAH syndrome.
The strengths of the present study include the application of
two validated methods to determine hypoglycaemia awareness
status [42] and the use of an extensive battery of validated
cognitive tests [25, 31, 35]. In addition, the use of strict criteria
for inclusion in the statistical analyses excluded participants
with IAH with the greatest performance impairments: only par-
ticipants with IAH with the best cognitive function were com-
pared with participants with NAH. Thus, the observed group
differences in cognition between participants with IAH and
NAH probably represented the minimum difference. The sim-
ilar demographic and disorder-specific characteristics in the
IAH and NAH groups, as well as in those participants who
declined participation, are further strengths of this study. In
the Norwegian Diabetes Registry [43], the average age, diabe-
tes duration and HbA1c level in people with type 1 diabetes was
41.8 years, 20.8 years and 8.0%, respectively, i.e. quite similar
to the measures in the present study, which supports the
generalisability of the present findings. Furthermore, the prev-
alence of microvascular complications and the level of educa-
tional attainment were similar in the IAH and NAH groups, and
are therefore unlikely to have confounded the results.
The limitations of the study include the lack of measure-
ment of participants’ premorbid cognitive function and the
relatively modest sample size. While these may contribute to
selection bias, there is no reason to believe that those eligible
candidates who declined participation in the study had higher
or lower cognitive abilities than people with type 1 diabetes in
general. In addition, participants with NAH were chosen at
random to reduce selection bias. Moreover, pre-test power
analyses indicated that the proposed number of participants
would be sufficient to yield clinically significant results.
It could be argued that participants should have been assessed
using a continuous glucosemonitoring system before commenc-
ing the study to identify asymptomatic biochemical
hypoglycaemia that may influence cognitive function.
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Although cognition is impaired during hypoglycaemia and may
remain abnormal for 40–75 min after hypoglycaemia has been
treated [34], people with IAH have been shown to be less af-
fected by hypoglycaemia compared with people with NAH and
to recover more quickly [34]. As cognitive function is less af-
fected by hypoglycaemia in people with IAH than those with
NAH [34], any unrecognised biochemical hypoglycaemia in
participants before the study would have been more likely to
result in poorer performance in those with NAH, and would
therefore not explain the present findings. Hyperglycaemia has
also been found to impair cognitive function [44, 45], but an
upper limit for the plasma glucose level was not specified before
cognitive testing commenced. However, plasma glucose levels
before and after testing were similar in the IAH and NAH
groups (Table 1), with no association being found between ele-
vated glucose levels and poorer cognitive performance.
As participants were not observed during cognitive testing, it
is possible that they could have used aids when self-
administering the cognitive tests, although they were instructed
not to. The design of most tests made them impervious to at-
tempts at cheating and the test platform did not allow individ-
uals to redo tests. Based on the time stamps of keyboard strokes
and the duration of each test session, it is very unlikely that any
of the participants used aids while performing the tests.
The results of the present study are of considerable rele-
vance to people with type 1 diabetes. The modest cognitive
impairment observed in people with IAH may contribute to
their increased risk of developing severe hypoglycaemia, and
emphasises the necessity to reinforce structured education by
using psychotherapeutic and behavioural therapies, and
utilising diabetes technologies to avoid SH [46]. It has been
suggested that impaired cognition may underlie the resistance
shown by some people with IAH to co-operate in interven-
tions to restore awareness of hypoglycaemia [47]. The present
observations underline the value of including cognitive tests
in intervention programmes to evaluate whether impaired cog-
nitive ability may affect adherence to treatment and outcomes.
Conclusion
The present study has demonstrated significant impairments
in learning, memory, pattern separation and aspects of execu-
tive function (specifically, planning ability) in adults with type
1 diabetes who have IAH. These findings suggest that recur-
rent SH may have a role in promoting cognitive deficits in
people with impaired hypoglycaemia awareness.
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